76 related articles for article (PubMed ID: 23469787)
1. [Role of chemokine receptor 2 in renal damage induced by deoxycorticosterone acetate-salt hypertension].
Sun M; Cui L; Liu WH; Gao Y; Shen S; Zhu MJ; Wang YP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Feb; 35(1):29-35. PubMed ID: 23469787
[TBL] [Abstract][Full Text] [Related]
2. [Role of transient receptor potential vanilloid type 1 and C-C chemokine receptor 2 in renal injury induced by salt-sensitive hype].
Zhu FY; Liu WH; Wang XX; Cui L; Shen S; Zhu MJ; Wang YP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Oct; 36(5):488-95. PubMed ID: 25360645
[TBL] [Abstract][Full Text] [Related]
3. Role of the monocyte chemoattractant protein-1/C-C chemokine receptor 2 signaling pathway in transient receptor potential vanilloid type 1 ablation-induced renal injury in salt-sensitive hypertension.
Wang Y; Zhu M; Xu H; Cui L; Liu W; Wang X; Shen S; Wang DH
Exp Biol Med (Maywood); 2015 Sep; 240(9):1223-34. PubMed ID: 25585624
[TBL] [Abstract][Full Text] [Related]
4. Reversal of vascular macrophage accumulation and hypertension by a CCR2 antagonist in deoxycorticosterone/salt-treated mice.
Chan CT; Moore JP; Budzyn K; Guida E; Diep H; Vinh A; Jones ES; Widdop RE; Armitage JA; Sakkal S; Ricardo SD; Sobey CG; Drummond GR
Hypertension; 2012 Nov; 60(5):1207-12. PubMed ID: 23033370
[TBL] [Abstract][Full Text] [Related]
5. Triptolide attenuates renal damage by limiting inflammatory responses in DOCA-salt hypertension.
Zhang J; Zhu M; Zhang S; Xie S; Gao Y; Wang Y
Int Immunopharmacol; 2020 Dec; 89(Pt A):107035. PubMed ID: 33045566
[TBL] [Abstract][Full Text] [Related]
6. Role of substance P in renal injury during DOCA-salt hypertension.
Wang Y; Wang DH
Endocrinology; 2012 Dec; 153(12):5972-9. PubMed ID: 23024265
[TBL] [Abstract][Full Text] [Related]
7. Role of angiotensin II in cerebrovascular and renal damage in deoxycorticosterone acetate-salt hypertensive rats.
Wada T; Kanagawa R; Ishimura Y; Inada Y; Nishikawa K
J Hypertens; 1995 Jan; 13(1):113-22. PubMed ID: 7759841
[TBL] [Abstract][Full Text] [Related]
8. Deletion of transient receptor potential vanilloid type 1 receptors exaggerates renal damage in deoxycorticosterone acetate-salt hypertension.
Wang Y; Babánková D; Huang J; Swain GM; Wang DH
Hypertension; 2008 Aug; 52(2):264-70. PubMed ID: 18606907
[TBL] [Abstract][Full Text] [Related]
9. P2X7 deficiency attenuates hypertension and renal injury in deoxycorticosterone acetate-salt hypertension.
Ji X; Naito Y; Weng H; Endo K; Ma X; Iwai N
Am J Physiol Renal Physiol; 2012 Oct; 303(8):F1207-15. PubMed ID: 22859404
[TBL] [Abstract][Full Text] [Related]
10. Aggravated renal inflammatory responses in TRPV1 gene knockout mice subjected to DOCA-salt hypertension.
Wang Y; Wang DH
Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1550-9. PubMed ID: 19794112
[TBL] [Abstract][Full Text] [Related]
11. Renal protective effects of N-acetyl-Ser-Asp-Lys-Pro in deoxycorticosterone acetate-salt hypertensive mice.
Rhaleb NE; Pokharel S; Sharma U; Carretero OA
J Hypertens; 2011 Feb; 29(2):330-8. PubMed ID: 21052020
[TBL] [Abstract][Full Text] [Related]
12. L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats.
Toba H; Yoshida M; Tojo C; Nakano A; Oshima Y; Kojima Y; Noda K; Wang J; Kobara M; Nakata T
Hypertens Res; 2011 Apr; 34(4):521-9. PubMed ID: 21270815
[TBL] [Abstract][Full Text] [Related]
13. Anakinra reduces blood pressure and renal fibrosis in one kidney/DOCA/salt-induced hypertension.
Ling YH; Krishnan SM; Chan CT; Diep H; Ferens D; Chin-Dusting J; Kemp-Harper BK; Samuel CS; Hewitson TD; Latz E; Mansell A; Sobey CG; Drummond GR
Pharmacol Res; 2017 Feb; 116():77-86. PubMed ID: 27986554
[TBL] [Abstract][Full Text] [Related]
14. Obesity induced renal oxidative stress contributes to renal injury in salt-sensitive hypertension.
Quigley JE; Elmarakby AA; Knight SF; Manhiani MM; Stepp DW; Olearzcyk JJ; Imig JD
Clin Exp Pharmacol Physiol; 2009 Jul; 36(7):724-8. PubMed ID: 19207724
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of renal oxidative stress in the development of DOCA-salt induced hypertension and its renal damage.
Seifi B; Kadkhodaee M; Karimian SM; Zahmatkesh M; Xu J; Soleimani M
Clin Exp Hypertens; 2010 Jan; 32(2):90-7. PubMed ID: 20374182
[TBL] [Abstract][Full Text] [Related]
16. Dietary chloride does not correlate with urinary thromboxane in deoxycorticosterone acetate-treated rats.
Theriot JA; Passmore JC; Jimenez AE; Fleming JT
J Lab Clin Med; 2000 Jun; 135(6):493-7. PubMed ID: 10850649
[TBL] [Abstract][Full Text] [Related]
17. Strain differences in the development of hypertension and glomerular lesions induced by deoxycorticosterone acetate salt in mice.
Hartner A; Cordasic N; Klanke B; Veelken R; Hilgers KF
Nephrol Dial Transplant; 2003 Oct; 18(10):1999-2004. PubMed ID: 13679473
[TBL] [Abstract][Full Text] [Related]
18. Role of angiotensin II type 1a receptor in renal injury induced by deoxycorticosterone acetate-salt hypertension.
Hisamichi M; Kamijo-Ikemori A; Sugaya T; Ichikawa D; Natsuki T; Hoshino S; Kimura K; Shibagaki Y
FASEB J; 2017 Jan; 31(1):72-84. PubMed ID: 27663860
[TBL] [Abstract][Full Text] [Related]
19. Rosiglitazone prevents the progression of renal injury in DOCA-salt hypertensive rats.
Bae EH; Kim IJ; Ma SK; Kim SW
Hypertens Res; 2010 Mar; 33(3):255-62. PubMed ID: 20057489
[TBL] [Abstract][Full Text] [Related]
20. Renal Inflammation in DOCA-Salt Hypertension.
Banek CT; Gauthier MM; Van Helden DA; Fink GD; Osborn JW
Hypertension; 2019 May; 73(5):1079-1086. PubMed ID: 30879356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
